Elevate Your Atrial Fibrillation Practice: Key Takeaways on Diagnosis and Management

Authors

• Edisson Naranjo-Mejia, University of LynchburgFollow

Advisor

Debra Munsell, DHSc, PA-C, DFAAPA

Abstract

ABSTRACT

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, characterized by uncoordinated electrical activity, demonstrates a prevalence that scales significantly with age. While its prevalence poses a substantial public health burden, driving hundreds of thousands of annual hospitalizations, timely detection, now increasingly supported by consumer electronic devices, and effective intervention are crucial for mitigating associated complications. To establish a definitive diagnosis, a 12-lead electrocardiogram or a rhythm strip must demonstrate absent P waves and irregular RR intervals. Once identified, clinicians categorize the rhythm by duration, such as paroxysmal (spontaneous termination within 7 days), persistent (sustained beyond 7 days), or permanent, which subsequently informs the core therapeutic strategy. Management centers on three primary pillars, including heart rate management, rhythm maintenance, and thrombotic prevention through anticoagulation. Regarding rate control, beta-blockers are the primary strategy for asymptomatic patients to maintain a resting heart rate of < 110 beats per minute. Alternatively, rhythm control, which involves restoration of sinus rhythm, may be achieved with antiarrhythmic drugs, cardioversion, or catheter ablation; specifically, pulmonary vein isolation has emerged as a highly effective strategy for symptomatic patients. In parallel with rate and rhythm management, anticoagulation is essential for stroke prevention. By stratifying risk via the CHA₂DS₂-VASc score, clinicians can appropriately prescribe direct oral anticoagulants or warfarin for high-risk individuals. Beyond these standard pharmacological and procedural interventions, emerging research underscores the critical importance of addressing underlying comorbidities such as hypertension, obesity, and obstructive sleep apnea. Early identification and rigorous management of these substrates can significantly improve patient outcomes and procedural success rates. Ultimately, a comprehensive approach integrating clinical therapy with aggressive lifestyle and risk factor modifications is imperative to reduce the overall AF burden and enhance the long-term quality of life for those afflicted by this condition, thereby actively ensuring better health outcomes, reducing mortality risks, minimizing future hospital visits, and providing a more stable, proactive pathway toward sustainable cardiovascular wellness for all the affected patients who are currently navigating the complexities of their cardiac diagnosis.

Recommended Citation

Naranjo-Mejia E. Elevate Your Atrial Fibrillation Practice: Key Takeaways on Diagnosis and Management. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2026; 8(1).